Literature DB >> 28157478

Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis.

Hans L Rieder1, Armand Van Deun2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28157478     DOI： 10.5588/ijtld.16.0619

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  6 in total

1.  Eligibility for a Shorter Treatment Regimen for Multidrug-resistant Tuberculosis in the United States, 2011-2016.

Authors:  Clarisse A Tsang; Neha Shah; Lori R Armstrong; Suzanne M Marks
Journal:  Clin Infect Dis       Date:  2020-02-14       Impact factor: 9.079

2.  Improved Outcomes With High-dose Isoniazid in Multidrug-resistant Tuberculosis Treatment in Haiti.

Authors:  Kathleen F Walsh; Stalz Charles Vilbrun; Ariadne Souroutzidis; Sobieskye Delva; Guy Joissaint; Laurent Mathurin; Oksana Ocheretina; Pierre Cremieux; Jean William Pape; Serena P Koenig
Journal:  Clin Infect Dis       Date:  2019-08-01       Impact factor: 9.079

3.  A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial.

Authors:  Kamunkhwala Gausi; Elisa H Ignatius; Xin Sun; Soyeon Kim; Laura Moran; Lubbe Wiesner; Florian von Groote-Bidlingmaier; Richard Hafner; Kathleen Donahue; Naadira Vanker; Susan L Rosenkranz; Susan Swindells; Andreas H Diacon; Eric L Nuermberger; Kelly E Dooley; Paolo Denti
Journal:  Am J Respir Crit Care Med       Date:  2021-12-01       Impact factor: 21.405

Review 4.  Current tools available for the diagnosis of drug-resistant tuberculosis.

Authors:  Christopher Gilpin; A Korobitsyn; K Weyer
Journal:  Ther Adv Infect Dis       Date:  2016-10-14

5.  Speeding up the diagnosis of multidrug-resistant tuberculosis in a high-burden region with the use of a commercial line probe assay.

Authors:  Angela Pires Brandao; Juliana Maira Watanabe Pinhata; Rosangela Siqueira Oliveira; Vera Maria Neder Galesi; Helio Hehl Caiaffa-Filho; Lucilaine Ferrazoli
Journal:  J Bras Pneumol       Date:  2019-04-18       Impact factor: 2.624

6.  Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations.

Authors:  Pauline Lempens; Conor J Meehan; Koen Vandelannoote; Kristina Fissette; Pim de Rijk; Armand Van Deun; Leen Rigouts; Bouke C de Jong
Journal:  Sci Rep       Date:  2018-02-19       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.